Axon Dx is a company that develops imaging technologies and products that provide greater cellular insights into disease biology. Their nCyte platform offers the opportunity for morphological and targeted molecular characterization of CTCs and other rare cells in an affordable format. They are dedicated to providing research tools that make hunting for rare cells, such as circulating tumor cells or circulating endothelial cells, a simple diagnostic test. Enhanced scanning optical systems powered by artificial intelligence coupled with state-of-the-art biomarkers are just some of the tools they offer.
However, their website has a contact page where you can reach out to them for more information.
In terms of categories, Axon Dx is focused on developing instruments and reagents that allow rapid, minimally invasive analysis of the CTCs shed by the primary and metastatic tumors. With a simple blood draw, the researcher will be able to identify and count the CTCs in a patient’s sample.
However, there are other companies that offer similar products such as Epic Sciences, Biocept, and Cynvenio.
Member count: 11-50
Investors 1
| Date | Name | Website |
| - | Shenandoah... | svangelinv... |